Chemed Corporation (CHE)

CIK 0000019584 · Healthcare · Medical Care Facilities

Recent Filing Index

Form Filed Qtr End F_Period 8K: Earnings Release
Latest Q2-2026 8-K (2026-07-28) · 99.1
Q1-2026 8-K (2026-04-23) · 99.1
Latest FY-2025 8-K (2026-02-25) · 99.1
Q3-2025 8-K (2025-10-28) · 99.1
Q2-2025 8-K (2025-07-29) · 99.1
Q1-2025 8-K (2025-04-23) · 99.1
FY-2024
FY-2024 8-K (2025-02-26) · 99.1
Q3-2024 8-K (2024-10-29) · 99.1
Q2-2024 8-K (2024-07-24) · 99.1
Q1-2024 8-K (2024-04-24) · 99.1
FY-2023 8-K (2024-02-27) · 99.1
Q3-2023 8-K (2023-10-25) · 99.1

Filing Summary

Report Name | Notes Fiscal Period (Annual) Fiscal Period (Quarter)
Document and Entity Information
Insider Trading Policies and Procedures
—
Statements
Consolidated Balance Sheets
Consolidated Balance Sheets (P)
Consolidated Statements of Income
Consolidated Statements of Cash Flows
Consolidated Statements of Changes In Stockholders' Equity
Consolidated Statements of Changes In Stockholders' Equity (P)
Notes
Acquisitions
Basis of Presentation
—
Capital Stock Repurchase Plan Transactions
Capital Stock Transactions
—
Cash Overdrafts and Cash Equivalents
—
Cash Overdrafts, Cash Equivalents and Supplemental Cash Flow Disclosure
—
Cash Overdrafts, Cash Equivalents, and Supplemental Cash Flow Disclosure
—
Concentration of Risk
—
Cybersecurity Risk Management and Strategy Disclosure
—
Discontinued Operations
—
Earnings Per Share
Financial Instruments
Income Taxes
—
Intangible Assets
—
Leases
Legal and Regulatory Matters
Long-term Debt and Lines of Credit
Other Assets
Other Current Liabilities
Other Income Net
Other Income €“ Net
—
Other Income/(expense) Net
Other Operating Expenses
—
Properties and Equipment
—
Recent Accounting Standards
Retirement Plans
Revenue Recognition
Segments
—
Segments and Nature of The Business
—
Stock-based Compensation Plans
Subsequent Event
—
Summary of Significant Accounting Policies
—